(Q33975309)

30 July 2017

1 reference

title

Childhood autoimmune neurologic diseases of the central nervous system (English)

1 reference

30 July 2017

Charlotte T Jones

1

1 reference

30 July 2017

publication date

1 November 2003

1 reference

30 July 2017

1 reference

30 July 2017

volume

21

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

745-764

1 reference

Postinfectious and vaccinal encephalitis

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Serial magnetic resonance imaging in children with postinfectious encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Measles Encephalomyelitis — Clinical and Immunologic Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Pathogenesis of multiple sclerosis: an update on immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Genetics of childhood disorders: XXIX. Autoimmune disorders, part 2: Molecular mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Childhood acute disseminated encephalomyelitis: the role of brain and spinal cord MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Postinfectious encephalomyelitis: etiologic and diagnostic trends

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

ADEM: literature review and case report of acute psychosis presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Postinfectious cerebellitis: clinical significance of Tc-99m HMPAO brain SPECT compared with MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

CORTICOSTEROID TREATMENT FOR ACUTE MENINGOENCEPHALITIS: A RETROSPECTIVE STUDY OF 346 CASES.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Steroid-responsive encephalomyelitis in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute disseminated encephalomyelitis: response to intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Plasmapheresis in a child affected by acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute disseminated encephalomyelitis in childhood: report of 10 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Recurrent encephalomyelitis in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

The epidemiology of multiple sclerosis: a general overview

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Multiphasic disseminated encephalomyelitis presenting as alternating hemiplegia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

A long perspective on childhood multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Early onset MS under the age of 16: clinical and paraclinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Multiple sclerosis in childhood: clinical features of 149 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Multiple sclerosis in children under 6 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Multiple sclerosis in childhood: clinical profile in 125 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Multiple sclerosis in childhood: report of 16 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Definite and suspected multiple sclerosis in children: long-term follow-up and magnetic resonance imaging findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Optic neuritis in children: recurrence and subsequent development of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Recovery after optic neuritis in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

The controlled high risk Avonex multiple sclerosis trial (CHAMPS Study).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Interferon beta-1a in children with multiple sclerosis is well tolerated

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Interferon-beta treatment in patients with childhood-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Long-term MRI observations of childhood-onset relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute transverse myelitis: incidence and etiologic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute transverse myelitis: a retrospective study using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Residual bladder dysfunction 2 to 10 years after acute transverse myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute transverse myelopathy in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Characteristics and course of urinary tract dysfunction after acute transverse myelitis in

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Rapid onset transverse myelitis in adolescence: implications for pathogenesis and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Transverse myelitis. Comparison with spinal cord presentations of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Acute transverse myelitis in a 7-month-old boy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

High dose methylprednisolone in severe acute transverse myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Rapid recovery from transverse myelopathy in children treated with methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Is methyl prednisolone useful in acute transverse myelitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Optic neuritis in children and its relationship to multiple sclerosis: a clinical study of 21 children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Bilateral retrobulbar optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Bilateral postinfectious optic neuritis and intravenous steroid therapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Optic neuritis in children with poor recovery of vision

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

Optic neuritis treatment trial. One-year follow-up results

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900007-0

7 January 2021

10.1016/S0733-8619(03)00007-0

Identifiers

DOI

1 reference

30 July 2017

1 reference